Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2) is a regulatory subunit of the AMP-activated protein kinase (AMPK) complex, which acts as a key cellular energy sensor. The AMPK heterotrimer consists of a catalytic alpha subunit and regulatory beta (including PRKAB2) and gamma subunits. Upon cellular energy stress, AMPK is activated, shifting cellular metabolism toward energy-generating processes while inhibiting anabolic pathways such as fatty acid and cholesterol synthesis. The PRKAB2-encoded beta-2 subunit serves as a scaffold crucial for assembly and stabilization of the AMPK complex and contributes to tissue specificity—being highly expressed in skeletal muscle and also implicated in cardiac and neuronal development. PRKAB2 has been functionally associated with various metabolic diseases, cancer, and neurodevelopmental syndromes, and is targeted by drugs that modulate AMPK activity—either directly or indirectly. PRKAB2 is considered a bona fide therapeutic target due to its central role in cellular metabolism and disease.
Activation of the AMPK complex, leading to phosphorylation and inactivation of metabolic enzymes (e.g., ACC, HMGCR), shifting the cell from anabolic to catabolic metabolism and inhibiting cell growth and biosynthetic processes. Regulation of AMPK localization and assembly through post-translational modification of PRKAB2 (e.g., ubiquitination, sumoylation).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2).